Refine your search
Collections
Co-Authors
Journals
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All
Hapse, S. A.
- An Ebola: Overview
Abstract Views :400 |
PDF Views:0
Authors
Affiliations
1 Department of Quality Assurance Technique, P.D.V.V.P.F'S College of Pharmacy, Ahmednagar, IN
2 H.S.B.P.V.T. College of Pharmacy, Kashti Tal. Shrigonda, Ahmednagar, IN
1 Department of Quality Assurance Technique, P.D.V.V.P.F'S College of Pharmacy, Ahmednagar, IN
2 H.S.B.P.V.T. College of Pharmacy, Kashti Tal. Shrigonda, Ahmednagar, IN
Source
Research Journal of Pharmacology and Pharmacodynamics, Vol 6, No 4 (2014), Pagination: 204-209Abstract
Ebola hemorrhagic fever (Ebola HF) is a severe, often-fatal disease in humans and nonhuman primates (monkeys and chimpanzees) that has appeared sporadically since its initial recognition in 1976.Most species of ebolavirus and the only known species of virus occur in Africa. Primates are infected sporadically from an unknown source; current evidence suggests that the reservoir hosts are probably bats. Humans seem to become infected directly from bats in caves, as well as when they contact tissues from infected apes and other species. Once the virus has entered the population, it can spread from person to person. Some epidemics affect hundreds of people and decimate entire villages, particularly where hospital facilities and medical supplies are inadequate and nosocomial spread occurs. Although the mortality rate varies, the most pathogenic viruses kill up to 90% of those who become infected. No vaccine is available, and the only treatment is supportive.Keywords
Ebola Virus Disease, Haemorrhagic Fever, Ebola Virus Outbreak.References
- Peters CJ, Le Duc JW. An introduction to Ebola: the virus and the disease. J Infect Dis 1999; 179 (Suppl 1): ix-xvi.
- World Health Organization (WHO) Media Center: Ebola virus disease. Fact sheet No. 103.
- Leroy EM, Kumulungui B, Pourrut X, Rouquet P, Hassanin A, Yaba P, Delicat A, Paweska JT, Gonzalez JP, Swanepoel R. Fruit bats as reservoirs of Ebola virus. Nature 2005; 438:575-6.
- Rodriguez LL, De Roo A, Guimard Y, Trappier SG, Sanchez A, Bressler D,Williams AJ, Rowe AK, Bertolli J Khan AS, Ksiazek TG, Peters CJ, Nichol ST. Persistence and genetic stability of Ebola virus during the outbreak in Kikwit, Democratic Republic of the Congo, 1995. J Infect Dis 1999; 179 (Suppl 1):S170-6.
- Bermejo M, Rodriguez- Teijeiro JD, Illera G, Barroso A, Vilà C, Walsh PD. Ebola outbreak killed 5000 gorillas. Science 2006; 314:1564.
- Sanchez A, Geisbert CW, Feldman H. Filoviridae: Marburg and Ebola viruses. In: Knipe DM, Howley PM, editors. Fields virology, 5th ed. Philadelphia: Lippincott, Williams &Wilkins 2007. pp. 1409-48
- Olsen SJ, Chang HL, Cheung TY, Tang AF, Fisk TL, et al. (2003) Transmission of the severe acute respiratory syndrome on aircraft. N Engl J Med 349: 2416- 2422.
- European Centre for Disease Prevention and Control (ECDC) (2014) Updated 8 April. Outbreak of Ebola virus disease in West Africa. ECDC, Stockholm.
- Centers for Disease Control and Prevention (CDC). Ebola haemorrhagic fevers. Outbreak of Ebola in Guinea and Liberia.
- Lee, J.E.; Fusco, M.L.; Hessell, A.J.; Oswald, W.B.; Burton, D.R. and Saphire, E.O. (2008) Structure of the Ebola virus glycoprotein bound to an antibody from a human survivor. Nature. 454:177-182.
- Cacciotti I , Aspetti PC, Cenciarelli O, Carestia M, Di Giovanni D, et al. (2014) Simulation of Caesium-137 (137Cs) Local Diffusion as a Consequence of the Chernobyl Accident Using Hotspot. Defence S&T Technical Bullettin 7: 18-26.
- European Commission, SANCO-Public Health Directorate, G4 Unit-Communicable, Rare and Emerging Diseases (2003) Measures undertajen by member states and accession countries to control the outbreak of SARS.
- Cenciarelli O, Pietropaoli S, Frusteri L, Malizia A, Carestia M, et al. (2014) Biological Emergency Management: The Case of Ebola 2014 and the Air Transportation Involvement. J Microb Biochem Technol 6:247-253.doi:10.4172/1948-5948.100.
- Cleaning Validation of Paracetamol Tablets as a Dosage Formulation
Abstract Views :292 |
PDF Views:0
Authors
Affiliations
1 Department of Quality Assurance Technique, Padmashree Dr. Vithalrao Vikhe Patil College of Pharmacy, Ahmednagar, Maharashtra. 414111, IN
1 Department of Quality Assurance Technique, Padmashree Dr. Vithalrao Vikhe Patil College of Pharmacy, Ahmednagar, Maharashtra. 414111, IN
Source
Research Journal of Pharmaceutical Dosage Form and Technology, Vol 3, No 5 (2011), Pagination: 215-219Abstract
Cross contamination is one of the major problems focused in manufacturing of drugs utilizing common facility which leads to inferior quality of final product and cause considerable loss to the company. Contamination of one batch product with significant levels of residual active ingredients from a previous batch and contamination by microorganisms are the real concern. Cleaning and decontamination is one of the major and critical activity in pharmaceutical operations. The concept of purity and safety are directly related to the cleaning operations. Cleaning programmers are necessary simply to prevent our manufactured products from being contaminated. These are cross-contamination of one product into another , product contamination by a foreign material and microbial contamination The cleaning validation is a documented process that proves the effectiveness and consistency cleaning of pharmaceutical equipments to meet the regulatory requirements. Manufacturing of paracetamol and other tablets utilizing common facility, where paracetamol could be a possible cross contaminant. Hence the present study was carried out to validate the cleaning activity from both regulatory and quality prospective. Visual inspection, Swab sampling for chemical residue and for microbiological analysis were carried out to validate cleaning activity and results from all methods were complying with acceptance criteria.Keywords
Paracetamol, Sodium Lauryl Sulphate, Cross Contamination, Cleaning Validation.- Study and Evaluation of Dry Powder Inhaler-A Review
Abstract Views :301 |
PDF Views:0
Authors
Affiliations
1 Padmashree Dr.Vithalrao Vikhe Patil Foundation’s College of Pharmacy, Vilad Ghat, MIDC, Ahmednagar (MS)-4141 11, IN
1 Padmashree Dr.Vithalrao Vikhe Patil Foundation’s College of Pharmacy, Vilad Ghat, MIDC, Ahmednagar (MS)-4141 11, IN
Source
Research Journal of Pharmaceutical Dosage Form and Technology, Vol 3, No 3 (2011), Pagination: 87-92Abstract
Dosage form used to deliver drug via lungs can be used to treat asthma, COPD, or Diabetes, For formulation of such dosage form require dry powder with very short list of expedients such as stabilizer, solubilizer, property modifier ( flow enhancer ) For which different secondary processing parameter are been carried out such as milling , spray drying, lyophilization. Now in today market different type of container are been packing for dry powder inhaler there are also been different evaluation test for the DPI.Keywords
Meter Dose Inhaler, Lyophilization, Control Release, Aerosol.- Studies in Process Validation of Ranitidine Hydrochloride Tablet 75 mg Dosage Formulation
Abstract Views :272 |
PDF Views:0
Authors
S. A. Hapse
1,
K. N. Tarkase
1
Affiliations
1 Padmashree Dr.Vithalrao Vikhe Patil Foundation’s College of Pharmacy, Vilad Ghat, MIDC, Ahmednagar (MS)-4141 11, IN
1 Padmashree Dr.Vithalrao Vikhe Patil Foundation’s College of Pharmacy, Vilad Ghat, MIDC, Ahmednagar (MS)-4141 11, IN
Source
Research Journal of Pharmaceutical Dosage Form and Technology, Vol 3, No 3 (2011), Pagination: 96-99Abstract
Documented evidence with a high degree of assurance that a process will consistently produce product, meeting its predetermined quality attributes is nothing but a process validation. In short process validation is checking of reproducibility of result. The critical process parameter was identified and evaluated by challenging its lower and upper release specification. The three process validation batches (PVB1, PVB2, PVB3) of same size, method, equipment and validation criteria was taken. The critical parameter involved in blending, compression, coating for our Ranitidine tablet were identified and evaluated as per the validation master plan. From the result we have found that in the same environmental condition there was no significant batch to batch variation and all the parameter studied were in accordance with the BMR.Keywords
Ranitidine Hydrochloride Tablet, Process Validation, BMR.- Mouth Dissolving Tablet:A Formulation Approach
Abstract Views :216 |
PDF Views:3
Authors
Affiliations
1 Dr.V.V.P.Fs College of Pharmacy, Vilad Ghat, Ahmednagar (MH), IN
1 Dr.V.V.P.Fs College of Pharmacy, Vilad Ghat, Ahmednagar (MH), IN